Capricor Therapeutics (CAPR) Stock Chart & Stock Price History → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free CAPR Stock Alerts $5.68 +0.13 (+2.34%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Capricor Therapeutics Stock Price Performance5 Day Performance-6.89%1 Month Performance+8.40%3 Month Performance+24.42%6 Month Performance+91.89%Year-To-Date Performance+16.16%1 Year Performance+24.84% Receive CAPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> CAPR Stock Chart for Sunday, June, 2, 2024 CAPR Chart by TradingView Capricor Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$5.55$5.68+2.34%$5.94$5.51385,867 shs$180.68 million05/30/2024$5.60$5.55-0.89%$5.65$5.41492,664 shs$176.55 million05/29/2024$6.10$5.60-8.20%$6.11$5.57608,204 shs$178.14 million05/28/2024$5.99$6.10+1.84%$6.14$5.64503,316 shs$194.05 million05/27/2024$5.99$5.99$6.07$5.90235,700 shs$190.54 million05/24/2024$6.07$5.99-1.32%$6.07$5.90233,813 shs$190.54 million Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$6.25$6.07-2.88%$6.25$6.02196,245 shs$193.09 million05/22/2024$6.29$6.25-0.64%$6.33$6.10322,059 shs$198.81 million05/21/2024$6.30$6.29-0.16%$6.34$6.03289,003 shs$200.09 million05/20/2024$6.20$6.30+1.61%$6.41$6.15404,354 shs$200.40 million05/17/2024$5.64$6.20+9.93%$6.53$5.79755,108 shs$197.22 million05/16/2024$5.33$5.64+5.82%$5.80$5.27497,758 shs$177.66 million05/15/2024$5.20$5.33+2.50%$5.47$5.21284,210 shs$167.90 million05/14/2024$5.44$5.20-4.41%$5.47$5.00667,280 shs$163.80 million05/13/2024$5.30$5.44+2.64%$5.44$5.26193,629 shs$171.36 million05/10/2024$5.42$5.30-2.21%$5.50$5.23233,835 shs$166.97 million05/09/2024$5.37$5.42+0.93%$5.49$5.33111,219 shs$170.75 million05/08/2024$5.46$5.37-1.65%$5.48$5.25196,232 shs$169.17 million05/07/2024$5.53$5.46-1.27%$5.68$5.43362,751 shs$171.99 million05/06/2024$5.47$5.53+1.10%$5.57$5.45140,928 shs$174.20 million05/03/2024$5.24$5.47+4.39%$5.78$5.28259,829 shs$165.08 million05/02/2024$5.33$5.24-1.69%$5.40$5.20210,194 shs$165.06 million05/01/2024$5.27$5.33+1.14%$5.44$5.24171,034 shs$167.90 million04/30/2024$5.33$5.27-1.13%$5.48$5.16248,659 shs$166.01 million04/29/2024$5.41$5.33-1.48%$5.68$5.27447,877 shs$167.90 million04/26/2024$5.15$5.41+5.05%$5.49$5.12638,964 shs$170.42 million04/25/2024$5.04$5.15+2.18%$5.24$4.91387,928 shs$162.23 million04/24/2024$4.82$5.04+4.56%$5.65$5.00912,876 shs$158.78 million04/23/2024$4.94$4.82-2.43%$5.02$4.70478,470 shs$151.83 million04/22/2024$5.01$4.94-1.40%$5.11$4.92356,899 shs$155.61 million04/19/2024$5.05$5.01-0.79%$5.28$4.87354,006 shs$157.83 million04/18/2024$5.55$5.05-9.01%$5.65$4.69931,030 shs$159.08 million04/17/2024$5.93$5.55-6.41%$6.05$5.44477,863 shs$174.83 million04/16/2024$5.86$5.93+1.19%$6.03$5.71276,550 shs$186.80 million04/15/2024$6.25$5.86-6.24%$6.33$5.65344,645 shs$184.59 million04/12/2024$6.23$6.25+0.32%$6.29$6.03166,001 shs$196.88 million04/11/2024$6.30$6.23-1.11%$6.47$6.01372,854 shs$196.25 million04/10/2024$6.60$6.30-4.55%$6.71$6.06311,457 shs$198.45 million04/09/2024$6.58$6.60+0.30%$6.76$6.45225,826 shs$207.90 million04/08/2024$6.72$6.58-2.08%$6.80$6.54121,798 shs$207.27 millionBiotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>>04/05/2024$6.70$6.72+0.30%$6.82$6.51269,154 shs$211.70 million04/04/2024$6.80$6.70-1.47%$7.00$6.69238,304 shs$211.05 million04/03/2024$6.89$6.80-1.31%$7.06$6.64165,655 shs$214.20 million04/02/2024$7.10$6.89-2.89%$7.07$6.85189,417 shs$217.04 million04/01/2024$6.79$7.10+4.49%$7.28$6.73413,944 shs$223.49 million03/29/2024$6.79$6.79$6.94$6.60185,085 shs$213.89 million03/28/2024$6.77$6.79+0.30%$6.94$6.60184,878 shs$213.89 million03/27/2024$6.31$6.77+7.29%$7.04$6.19382,685 shs$213.26 million03/26/2024$6.63$6.31-4.83%$6.68$6.21336,590 shs$198.77 million03/25/2024$6.38$6.63+3.92%$6.66$5.96444,366 shs$208.87 million03/22/2024$6.88$6.38-7.27%$6.76$5.80740,562 shs$200.33 million03/21/2024$6.85$6.88+0.44%$7.04$6.72415,171 shs$216.03 million03/20/2024$6.79$6.85+0.88%$6.93$6.45398,349 shs$215.09 million03/19/2024$6.76$6.79+0.44%$7.22$6.67926,711 shs$213.21 million03/18/2024$6.39$6.76+5.79%$6.91$6.10527,066 shs$212.26 million03/15/2024$6.17$6.39+3.57%$6.68$6.07499,833 shs$200.65 million03/14/2024$5.94$6.17+3.87%$6.36$5.83281,217 shs$189.97 million03/13/2024$5.90$5.94+0.68%$6.05$5.79162,782 shs$182.89 million03/12/2024$5.80$5.90+1.72%$5.95$5.50306,883 shs$181.66 million03/11/2024$5.89$5.80-1.53%$6.19$5.69656,119 shs$178.60 million03/08/2024$5.04$5.89+16.87%$5.89$4.97712,947 shs$181.35 million03/07/2024$5.18$5.04-2.70%$5.26$4.86271,895 shs$155.18 million03/06/2024$4.96$5.18+4.54%$5.28$4.96343,175 shs$159.51 million03/05/2024$4.67$4.96+6.10%$5.03$4.64272,772 shs$152.56 million03/04/2024$4.57$4.67+2.30%$4.78$4.57203,973 shs$143.79 million03/01/2024$4.20$4.57+8.69%$4.69$4.21385,261 shs$140.56 million Related Companies: CLSD Stock Chart PRPH Stock Chart LPTX Stock Chart EYEN Stock Chart NRBO Stock Chart TNXP Stock Chart PRAX Stock Chart NRIX Stock Chart AUPH Stock Chart WVE Stock Chart Receive CAPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CAPR) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.